NAV
$36.01
AUM
$269.3M
Expense Ratio
-
Dividend Yield
0.00%
Beta
0.69
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +4.07% | +1.58% | -0.36% | +11.95% | +14.98% | +7.44% |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | SHEL.L | Shell PLC | 1.74% |
| 2 | AZN.L | AstraZeneca PLC | 1.55% |
| 3 | ROP.SW | Roche Holding AG Ordinary Shares new | 1.48% |
| 4 | NOVN.SW | Novartis AG Registered Shares | 1.42% |
| 5 | ENGI.PA | Engie SA | 1.34% |
| 6 | ELE.MC | Endesa SA | 1.33% |
| 7 | CNQ.TO | Canadian Natural Resources Ltd | 1.28% |
| 8 | SU.TO | Suncor Energy Inc | 1.21% |
| 9 | QBR-B.TO | Quebecor Inc Shs -B- Subord.Voting | 1.21% |
| 10 | EQNR.OL | Equinor ASA | 1.16% |
The fund invests at least 80% of its assets in securities included in the index and in depositary receipts representing securities included in the index. The index is designed to reflect the performance of stocks of large- and mid-capitalization developed international companies that have attractive valuations, high quality profiles, positive momentum signals, lower volatility than the broader developed international equity market, and lower correlation to the U.S. equity market.
Inception Date: 2019-02-26